AAV-mediated gene therapy for Alzheimer's disease: neuroprotective mechanisms and translational challenges

Abstract

Alzheimer's disease remains a major neurodegenerative disorder for which effective disease-modifying treatments are limited. Adeno-associated virus-mediated gene therapy provides a strategy for sustained modulation of disease-related pathways in the central nervous system.

The paper